CYP1A1 and breast cancer: Previous meta-analyses of maximum sample size was performed in 2014 for CYP1A1 T3801C (47 studies 16,272 case and 20,930 controls) and A2455G (38 studies 15,969 case and 24,931 controls) with BC risk [19, 21].